United Kingdom · 
Who invested in Pathios Therapeutics?
Pathios Therapeutics's investors include Canaan, Brandon Capital and Innovate UK.
20202021202220232024
$8.8MSeries A$25MSeries B
United Kingdom · Series B startup
Who invested in Pathios Therapeutics
Funding summaryUpdated 26 Oct 2026
$34Mraised across 2 rounds since 2019, from 2 sources
$8.8MSeries A$25MSeries B
- Latest round
- Series B, $25MApr 2024
- Step-upi
- 2.8×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $8.8M Dec 2019
- Biggest round
- $25M Series B · Apr 2024
- Between rounds
- 4.3 years from the last two
The rounds
- Apr 2024
- Dec 2019
Funding filed with regulators
Pathios Therapeutics filed one raise, $10.0M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Feb 2024$10.0MUK share allotment
Founders and team
From Pathios Therapeutics's own website: 2 founders, 11 on the team.
- Ann Taylor-HutchinsonChief Executive Officer
- Paul HighamChief Operating Officer
- Barbara Cipriani PhDHead of Clinical Operations
- James Westcott PhDHead of Corporate Governance & Business Operations Manager
- Lisa ShoesmithHead of People
- Alan Naylor PhDSenior Scientist
- Alastair Corbin DPhilSenior Scientist
- Andrea NisbetExecutive Assistant & Facilities Manager
- Debbie MacaroDirector, Clinical Operations
- Sam HarrisDirector of Finance
- Sean CarrollExecutive Assistant & Facilities Manager
AdvisersDavid Smith-ParkinPeter Joyce PhD
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Pathios Therapeutics
How much has Pathios Therapeutics raised?
Pathios Therapeutics has raised $34M across 2 rounds since 2019.
When did Pathios Therapeutics last raise?
Pathios Therapeutics's most recent round was a Series B of $25M in Apr 2024.
What was Pathios Therapeutics's biggest round?
Its most recent round, $25M in Apr 2024, is also its largest on record.
Who backed Pathios Therapeutics first?
Pathios Therapeutics's first round on record, in Dec 2019, was backed by Canaan and Brandon Capital.
What stage is Pathios Therapeutics at?
Pathios Therapeutics's latest named round is a Series B, in Apr 2024.
Where is Pathios Therapeutics based?
Pathios Therapeutics is based in the United Kingdom.
Companies like Pathios Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.